Weekly Recap | Novo Nordisk AS +3.54%, most brokers rate it holdWeekly Review·Oct 10, 2026 at 07:19 AMNVO-0.16%NVOX-0.21%
Weekly Recap | Novo Nordisk AS -3.81%, FDA extends denecimig reviewWeekly Review·Oct 3, 2026 at 07:23 AMNVO-0.16%
Weekly Recap | Novo Nordisk AS -10.27%, consensus target above spotWeekly Review·Sep 26, 2026 at 06:47 AMNVO-0.16%NVOX-0.21%
